Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) is pleased to announce a company presentation which details activities of its psychedelic therapies subsidiary company, called Psychennex.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Incannex Contact Information:

Incannex Healthcare LimitedMr Joel LathamManaging Director and Chief Executive Officer+61 409 840 786joel@incannex.com.au

Investor Relations Contact – United States Alyssa Factor Edison Group+1 (860) 573 9637afactor@edisongroup.com

Incannex Healthcare (NASDAQ:IXHL)
過去 株価チャート
から 4 2024 まで 5 2024 Incannex Healthcareのチャートをもっと見るにはこちらをクリック
Incannex Healthcare (NASDAQ:IXHL)
過去 株価チャート
から 5 2023 まで 5 2024 Incannex Healthcareのチャートをもっと見るにはこちらをクリック